Overview

Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension

Status:
Not yet recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Egito association in the treatment of type 2 diabetes mellitus and hypertension
Phase:
Phase 3
Details
Lead Sponsor:
EMS
Treatments:
Empagliflozin
Telmisartan